Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Huff

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Stroke|August 1, 1992
Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjectsO L Lopez, B S Rabin, F J Huff, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2010
The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbilR Lal, J Sukbuntherng, W Luo, et al.
Neuropsychologia|January 1, 1985
Visual agnosia contrasted with visual-verbal disconnectionG J Larrabee, H S Levin, F J Huff, et al.
The American Journal of Psychiatry|March 1, 1996
Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 yearsG S Zubenko, I Teply, E Winwood, et al.
Archives of Neurology|October 1, 1990
Brain imaging abnormalities in mental disorders of late lifeG S Zubenko, P Sullivan, J P Nelson, et al.
Spinal Cord|May 18, 2011
Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injuryP W Nance, F J Huff, A Martinez-Arizala, et al.
Neurology|July 1, 1987
Cognitive deficits and clinical diagnosis of Alzheimer's diseaseF J Huff, J T Becker, S H Belle, et al.
Aging (Milan, Italy)|September 1, 1990
The University of Pittsburgh Alzheimer's Disease Patient Registry: the Monongahela Valley Independent Elders Survey (MoVIES)L H Kuller, M Ganguli, G G Ratcliff, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1990
Serial sevens versus world backwards: a comparison of the two measures of attention from the MMSEM Ganguli, G Ratcliff, F J Huff, et al.
Life Sciences|January 1, 1995
A "bridging" (safety/tolerance) study of besipirdine hydrochloride in patients with Alzheimer's diseaseJ J Sramek, C Viereck, F J Huff, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Stroke|August 1, 1992
Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjectsO L Lopez, B S Rabin, F J Huff, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2010
The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbilR Lal, J Sukbuntherng, W Luo, et al.
Neuropsychologia|January 1, 1985
Visual agnosia contrasted with visual-verbal disconnectionG J Larrabee, H S Levin, F J Huff, et al.
The American Journal of Psychiatry|March 1, 1996
Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 yearsG S Zubenko, I Teply, E Winwood, et al.
Archives of Neurology|October 1, 1990
Brain imaging abnormalities in mental disorders of late lifeG S Zubenko, P Sullivan, J P Nelson, et al.
Spinal Cord|May 18, 2011
Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injuryP W Nance, F J Huff, A Martinez-Arizala, et al.
Neurology|July 1, 1987
Cognitive deficits and clinical diagnosis of Alzheimer's diseaseF J Huff, J T Becker, S H Belle, et al.
Aging (Milan, Italy)|September 1, 1990
The University of Pittsburgh Alzheimer's Disease Patient Registry: the Monongahela Valley Independent Elders Survey (MoVIES)L H Kuller, M Ganguli, G G Ratcliff, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1990
Serial sevens versus world backwards: a comparison of the two measures of attention from the MMSEM Ganguli, G Ratcliff, F J Huff, et al.
Life Sciences|January 1, 1995
A "bridging" (safety/tolerance) study of besipirdine hydrochloride in patients with Alzheimer's diseaseJ J Sramek, C Viereck, F J Huff, et al.
Pageof 5